L
L.-T. Chen
Researcher at National Health Research Institutes
Publications - 22
Citations - 812
L.-T. Chen is an academic researcher from National Health Research Institutes. The author has contributed to research in topics: Fluorouracil & Gemcitabine. The author has an hindex of 7, co-authored 22 publications receiving 496 citations.
Papers
More filters
Journal ArticleDOI
Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS.
Takayuki Yoshino,Dirk Arnold,Hiroya Taniguchi,George Pentheroudakis,Kentaro Yamazaki,R. Xu,Tae Won Kim,Fuad Ismail,Iain Beehuat Tan,K.-H. Yeh,Axel Grothey,S.Z. Zhang,Joong Bae Ahn,M. Y. Mastura,D. Chong,L.-T. Chen,Scott Kopetz,Takako Eguchi-Nakajima,Hiromichi Ebi,A. Ohtsu,Andrés Cervantes,K. Muro,Josep Tabernero,Hironobu Minami,Fortunato Ciardiello,J.-Y. Douillard +25 more
TL;DR: These guidelines represent the consensus opinions reached by experts in the treatment of patients with mCRC identified by the Presidents of the oncological societies of Japan (JSMO), China, Korea, Malaysia, Singapore, Singapore and Taiwan.
Journal ArticleDOI
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS.
K. Muro,E. Van Cutsem,Yukiya Narita,Georgios Pentheroudakis,Eishi Baba,Jian Li,Min-Hee Ryu,W.I. Wan Zamaniah,W.P. Yong,K.-H. Yeh,Kyoko Kato,Zhihao Lu,Byoung Chul Cho,I.M. Nor,M. Ng,L.-T. Chen,Takako Eguchi Nakajima,Kohei Shitara,Hisato Kawakami,Takahiro Tsushima,Takayuki Yoshino,Florian Lordick,Erika Martinelli,Elizabeth C Smyth,Dirk Arnold,Hironobu Minami,Josep Tabernero,J.-Y. Douillard +27 more
TL;DR: These guidelines represent the consensus opinions reached by experts in the treatment of patients with metastatic oesophageal cancer representing the oncological societies of Japan (JSMO), China (CSCO), Korea (KSMO), Malaysia (MOS), Singapore (SSO) and Taiwan (TOS).
Journal ArticleDOI
JSCO—ESMO—ASCO—JSMO—TOS: international expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions
Takayuki Yoshino,Georgios Pentheroudakis,Saori Mishima,Michael J. Overman,K.-H. Yeh,Eishi Baba,Yoichi Naito,F. Calvo,Ashish Saxena,L.-T. Chen,Masayuki Takeda,Andrés Cervantes,Hiroya Taniguchi,Kensaku Yoshida,Yasuhiro Kodera,Yuko Kitagawa,J. Tabernero,H. A. Burris,J.-Y. Douillard +18 more
TL;DR: The purpose of the meeting was to develop international expert consensus recommendations on the use of such tumour-agnostic treatments in patients with solid tumours, with a particular emphasis on diagnostic testing and patient selection.
Journal ArticleDOI
A randomized, phase Ib/II trial of rilotumumab (AMG 102; ril) or ganitumab (AMG 479; gan) with panitumumab (pmab) versus pmab alone in patients (pts) with wild-type (WT) KRAS metastatic colorectal cancer (mCRC): Primary and biomarker analyses.
Cathy Eng,E. Van Cutsem,Elżbieta Nowara,Anna Swieboda-Sadlej,Niall C. Tebbutt,Edith P. Mitchell,Irina Davidenko,Kelly S. Oliner,L.-T. Chen,Jing Huang,Ian McCaffery,Elwyn Loh,D. Smethurst,J. Tabernero +13 more
TL;DR: In this article, the safety and efficacy of ril or gan with pmab in pts with mCRC expressing WT KRAS was examined and a Bayesian approach was undertaken to determine a meaningful improvement in ORR in the combination arms.
Journal ArticleDOI
617OA Phase 3 Study of nivolumab (Nivo) in previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer: Updated results and subset analysis by PD-L1 expression (ATTRACTION-02)
Narikazu Boku,Y-K. Kang,T. Satoh,Yee Chao,Kyoko Kato,Hyun Cheol Chung,J. Y. Chen,K. Muro,Wonyoung Kang,Takaki Yoshikawa,Sang Cheul Oh,Takao Tamura,K-W. Lee,L.-T. Chen +13 more